International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net

ORIGINAL RESEARCH ARTICLE
Int J Pharm Bio Sci Volume 6 Issue 4, 2015 (October - December), Pages:46-69

DIABETES MELLITUS: RECENT ADVANCEMENT IN PPAR AGONISTS AS THERAPEUTIC AGENTS

 

GOPAL L. KHATIK*
DOI:
Abstract:

Diabetes mellitus is known as metabolic disorder related to glucose intolerance which is characterized by hyperglycemia. Diabetes mellitus can be treated by insulin and oral hypoglycemic agents. Most of known oral hypoglycemic are peroxisome proliferator-activated receptors (PPAR) agonist. There are three different subtypes of PPARs are identified and they are involved in glucose metabolism. A balanced PPARs agonist is required to avoid consequences related to over activation of one of the receptor subtypes. PPAR agonist has a good influence on activation of PPAR due to their chirality, therefore this review discusses the advancement and role of chirality on PPAR activation by PPAR agonists.

Keywords: Diabetes mellitus, hypoglycemia, PPAR agonist, oral hypoglycemic
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© 2009-2026 IJPBS, India. All rights reserved. Specialized online journals by ubijournal | Home | Contact | Terms & Conditions